Court Orders Cancer Treatment to End Backlog
Significant court ruling orders Gauteng Health to act on cancer treatment backlog, protecting patients' right to timely care.
Unregulated Glucose Monitors Pose Risk to Diabetics
Discover the implications of using unregulated glucose monitors and the urgent need for safety standards in diabetes care.
Zimbabwe Health Bill Aims for Universal Coverage
Zimbabwe health bill aims for universal healthcare with national health insurance and regulation of private hospitals.
Billions Lost to Fraud and Waste Cripple SA’s Private Healthcare
South Africa’s private healthcare sector is haemorrhaging up to R28 billion a year due to rampant fraud, waste, and abuse (FWA). This directly threatens the quality of care and financial stability of medical cover for millions of citizens…. Membership Required You must be a member to access this content.View Membership LevelsAlready a member? Log in...
Regulatory Delays Threaten Africa’s Pharmaceutical Ambition
Regulatory delays are hindering Africa's R1.25-trillion pharmaceutical manufacturing goals and access to markets.
HIV Testing Practices in Public Clinics Under Scrutiny
Patients in at least three South African provinces have claimed they are being forced to undergo HIV testing at government health facilities. Speaking on the condition of anonymity for fear of future victimisation, individuals in Gauteng, the Free State, and North West reported that HIV tests are being conducted without pre- or post-test counselling. In…...
AI in Medicine Leads to Doctor ‘Deskilling’
Uncover the potential risks of AI in medicine, particularly its effect on the skills of healthcare professionals over time.
Lack of Data on Foreign Healthcare Users Exposed
Health Minister Aaron Motsoaledi reveals a critical lack of data on foreign nationals in South Africa's public healthcare system.
Healthcare Crisis Demands Urgent Action Now
Explore the healthcare crisis in South Africa and how public-private partnerships can provide immediate solutions.
Lower Pharmaceutical Prices: Trump’s Bold Ultimatum
Trump demands lower pharmaceutical prices from major drug companies in a bold move to align US costs with global standards.